Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 11 December 1976:
Vol. 194. no. 4271, pp. 1243 - 1246
DOI: 10.1126/science.996552
Prev | Table of Contents | Next

Articles

Science, Vol 194, Issue 4271, 1243-1246
Copyright © 1976 by American Association for the Advancement of Science

articles

Low-risk cigarettes: a prescription

GB Gori

Antismoking education campaigns in out society have met with only partial success: today 55 to 60 million Americans smoke, and the habit is increasing among teenagers and women. It is important to protect individuals who continue to smoke despite all warnings. There is evidence that this can be accomplished in at least two ways. First, it may be possible to remove toxic smoke components and thus reduce specific hazards. Second, the doseresponse evidence suggests that, if the total intake of smoke can be reduced, after an appropriate time a reduction in disease incidence should occur. The technology to achieve these results has been developed and can be applied to the manufacture of commercial cigarettes. These cigarettes will not conform to traditional flavour patterns, but consumer perception can be made to change and compensating flavours and fragrances can be added. The feasibility of less hazardous cigarettes raises the question of whether there are limits of cigarette and smoke composition that may approach relative safety. These limits can be defined as the smoke intake doses at which the risk of disease in smokers approaches that in nonsmokers. Such values can be extimated by dose-response analysis of several epidemiological studies and by extrapolation of blood concentrations at different rates of intake for certain smoke components, such as carbon monoxide. Critical values determined by these methods should not be interpreted as indicators of safe smoking levels; they do imply, however, that a rapid shift in cigarette consumption habits toward the proposed range of values will make possible a substantial reduction in the current epidemic proportions of smoking-related diseases.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Estimating the health consequences of replacing cigarettes with nicotine inhalers.
W Sumner II (2003)
Tob. Control 12, 124-132
   Abstract »    Full Text »    PDF »
Whose standard is it, anyway? Author's reply.
R. R BAKER, F. JACOB, S. A. BIALOUS, and D. YACH (2001)
Tob. Control 10, 394-396
   Full Text »    PDF »
Historical perspective: the low tar lie.
D. R SHOPLAND (2001)
Tob. Control 10, i1-3
   Full Text »    PDF »
News media coverage of smoking and health is associated with changes in population rates of smoking cessation but not initiation.
J. P Pierce and E. A Gilpin (2001)
Tob. Control 10, 145-153
   Abstract »    Full Text »    PDF »
Tar and Nicotine Delivery of Cigarettes: What a Difference a Puff Makes.
L. T. Kozlowski (1981)
JAMA 245, 158-159
   Abstract »    PDF »
The regulation of carcinogenic hazards.
G. Gori (1980)
Science 208, 256-261
   PDF »
Less Hazardous Cigarette Debated.
G. H. Miller and J. Schumaker (1979)
JAMA 242, 1029
   Abstract »    PDF »
Less Hazardous Cigarette Debated-Reply.
G. B. Gori and C. J. Lynch (1979)
JAMA 242, 1029-1031
   Abstract »    PDF »
Development of Less Hazardous Cigarettes.
G. B. Gori and C. J. Lynch (1979)
JAMA 241, 2005
   Abstract »    PDF »
Cessation of Cigarette Smoking and Pulmonary Disease.
R. V. Ebert (1978)
JAMA 240, 2159-2161
   Abstract »    PDF »
Toward Less Hazardous Cigarettes: Current Advances.
G. B. Gori and C. J. Lynch (1978)
JAMA 240, 1255-1259
   Abstract »    PDF »
Macroeconomics of disease prevention in the United States.
G. Gori and B. Richter (1978)
Science 200, 1124-1130
   PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)